0 works0 citations0 h-indexGoogle ScholarOpenAlexNavid NamiResearch AreasPsoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin DiseasesMost-Cited Works→ A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited